We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

244 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $79.2M | Put options by funds: $41.4M

83% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 24

30% more funds holding in top 10

Funds holding in top 10: 10 → 13 (+3)

18% more capital invested

Capital invested by funds: $2.65B → $3.12B (+$473M)

8% more funds holding

Funds holding: 226 → 244 (+18)

2.6% more ownership

Funds ownership: 80.28% → 82.88% (+2.6%)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

Holders
244
Holders Change
+18
Holders Change %
+7.96%
% of All Funds
3.56%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
44
Increased
70
Reduced
88
Closed
24
Calls
$79.2M
Puts
$41.4M
Net Calls
+$37.9M
Net Calls Change
+$18.3M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62.9M
2
PA
Perceptive Advisors
New York
+$37.2M
3
Millennium Management
Millennium Management
New York
+$27.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.4M
5
BlackRock
BlackRock
New York
+$20.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$65.3M
2
NIP
Nicholas Investment Partners
California
-$20.9M
3
SCM
Soleus Capital Management
Connecticut
-$16.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$13.8M
5
BI
BVF Inc
California
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
DADC
151
D.A. Davidson & Co
Montana
$576K -$12.7K -190 -3%
Teacher Retirement System of Texas
152
Teacher Retirement System of Texas
Texas
$572K -$139K -2,079 -22%
Commonwealth Equity Services
153
Commonwealth Equity Services
Massachusetts
$560K +$20.1K +300 +4%
Creative Planning
154
Creative Planning
Kansas
$545K +$31K +464 +7%
TAM
155
Tocqueville Asset Management
New York
$533K +$33.4K +500 +8%
TRCT
156
Tower Research Capital (TRC)
New York
$519K +$398K +5,955 +1,043%
Ameriprise
157
Ameriprise
Minnesota
$489K -$1.54M -22,993 -79%
KAS
158
Kestra Advisory Services
Texas
$485K -$120K -1,802 -23%
SO
159
STRS Ohio
Ohio
$477K -$234K -3,500 -37%
Rafferty Asset Management
160
Rafferty Asset Management
New York
$465K +$85.4K +1,277 +28%
Zurich Cantonal Bank
161
Zurich Cantonal Bank
Switzerland
$464K -$126K -1,890 -24%
PRC
162
Pearl River Capital
Michigan
$462K -$276K -4,129 -42%
JGC
163
J. Goldman & Co
New York
$442K -$3.23M -48,256 -90%
CUAMC
164
China Universal Asset Management Company
China
$436K +$286K +4,271 +355%
RJA
165
Raymond James & Associates
Florida
$431K -$3.41K -51 -0.9%
PNC Financial Services Group
166
PNC Financial Services Group
Pennsylvania
$425K -$1.14K -17 -0.3%
Janney Montgomery Scott
167
Janney Montgomery Scott
Pennsylvania
$420K -$18.7K -280 -5%
Victory Capital Management
168
Victory Capital Management
Texas
$415K -$918K -13,726 -72%
AB
169
Amalgamated Bank
New York
$405K -$9.29K -139 -3%
Wolverine Trading
170
Wolverine Trading
Illinois
$403K -$35.7K -534 -10%
HAM
171
Harmony Asset Management
Arizona
$402K +$338K +5,057 New
P
172
Pitcairn
Pennsylvania
$395K -$9.23K -138 -3%
GPP
173
Great Point Partners
Connecticut
$395K +$332K +4,963 New
AP
174
AtonRa Partners
Switzerland
$372K -$33.6K -502 -10%
Osaic Holdings
175
Osaic Holdings
Arizona
$357K -$46.8K -700 -13%
5 6
7
8 9

AXSM Hedge Fund Activity: Q4 2023 in Review

244 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2023, worth a combined $3.12B — up 18% from $2.65B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AXSM positions and 24 closed out — a net gain of 20 holders — while 70 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62.9M. The largest seller was Fidelity Investments, cutting an estimated $65.3M.

  • 244 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2023, up from 226 in Q3 2023.
  • Funds reported $3.12B of Axsome Therapeutics stock for Q4 2023, up 18% quarter-over-quarter.
  • 44 funds opened new Axsome Therapeutics positions in Q4 2023 and 24 closed out, a net change of +20 holders.
  • The largest Axsome Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $62.9M added.
  • The largest Axsome Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $65.3M sold.

Based on aggregated 13F filings for Q4 2023.